Two new recommendations, calling for delaying the start and reducing the frequency of screening for breast and cervical cancer, have been met with anger and confusion from some corners, reports this article from the New York Times. The backers of science-driven medicine have cheered the elevation of data in the setting of standards. But many patients—and organizations of doctors and disease specialists—find themselves unready to accept the counterintuitive notion that more testing can be bad for your health, the Times reports.
